Abbvie Inc.

Abbott Laboratories Corporation

Abbott Gmbh & Co Kg

Katrin Schneider

Yi Gao

Jörg Breitenbach

Nancy E Sever

Ping Tong

Ulrich Westedt

Tapas Kumar Das

Ute Lander

Harald Hach

Adivaraha Jayasankar

Constanze Obermiller

Colleen Garrett

Michael Simon

Benedikt Steitz

Marius Naris

Thomas Mueller

Samuel Kyeremateng

Katharina Asmus

Regina Reul

Donghua Zhu

Gaurav C Patel

Ai Mey Chuah

Thomas K Kessler

Michael Siimon

Shreeram Sathya

The present invention features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes (1) a first layer which comprises 100 mg Compound 1, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion; and (2) a second layer which comprises 40 mg Compound 2, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion.

Solid pharmaceutical compositions for treating HCV

Growing community of inventors

Mannheim, Germany

Katrin Schneider